186 related articles for article (PubMed ID: 21827607)
1. A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions.
Hosokawa K; Ohnishi T; Kondo T; Fukasawa M; Koide T; Maruyama I; Tanaka KA
J Thromb Haemost; 2011 Oct; 9(10):2029-37. PubMed ID: 21827607
[TBL] [Abstract][Full Text] [Related]
2. A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.
Hosokawa K; Ohnishi T; Fukasawa M; Kondo T; Sameshima H; Koide T; Tanaka KA; Maruyama I
Microvasc Res; 2012 Mar; 83(2):154-61. PubMed ID: 22166857
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood.
Ogawa S; Szlam F; Dunn AL; Bolliger D; Ohnishi T; Hosokawa K; Tanaka KA
Haemophilia; 2012 Nov; 18(6):926-32. PubMed ID: 22642581
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Koide T; Maruyama I; Tanaka KA
PLoS One; 2014; 9(1):e86491. PubMed ID: 24497951
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
[TBL] [Abstract][Full Text] [Related]
6. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions.
Goto S; Tamura N; Ishida H
J Am Coll Cardiol; 2004 Jul; 44(2):316-23. PubMed ID: 15261925
[TBL] [Abstract][Full Text] [Related]
7. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
[TBL] [Abstract][Full Text] [Related]
8. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
9. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
Dangas G; Badimon JJ; Coller BS; Fallon JT; Sharma SK; Hayes RM; Meraj P; Ambrose JA; Marmur JD
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1342-9. PubMed ID: 9714143
[TBL] [Abstract][Full Text] [Related]
10. Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig.
André P; Arbeille B; Drouet V; Hainaud P; Bal dit Sollier C; Caen JP; Drouet LO
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):56-63. PubMed ID: 8548427
[TBL] [Abstract][Full Text] [Related]
11. Visual evaluation of blood coagulation during mural thrombogenesis under high shear blood flow.
Mizuno T; Sugimoto M; Matsui H; Hamada M; Shida Y; Yoshioka A
Thromb Res; 2008; 121(6):855-64. PubMed ID: 17900667
[TBL] [Abstract][Full Text] [Related]
12. A novel quantitative method to evaluate the contribution of platelet products to white thrombus formation in reconstituted blood under flow conditions.
Fuchizaki A; Yasui K; Hayashi T; Tanaka M; Nagasato T; Ohnishi-Wada T; Hosokawa K; Fujimura Y; Shimogaki K; Hirayama F; Takihara Y; Kimura T
Vox Sang; 2023 May; 118(5):367-375. PubMed ID: 36862116
[TBL] [Abstract][Full Text] [Related]
13. [Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
Shimazaki T; Goto S; Sakakibara M; Eto K; Kim JY; Ichikawa N; Yoshida M; Nagaoka Y; Isshiki T; Handa S
J Cardiol; 2000 Aug; 36(2):113-21. PubMed ID: 10955255
[TBL] [Abstract][Full Text] [Related]
14. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow.
Folie BJ; McIntire LV
Biophys J; 1989 Dec; 56(6):1121-41. PubMed ID: 2611327
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model.
Hosokawa K; Ohnishi-Wada T; Sameshima-Kaneko H; Nagasato T; Miura N; Kikuchi K; Koide T; Maruyama I; Urano T
Thromb Res; 2016 Oct; 146():69-75. PubMed ID: 27611498
[TBL] [Abstract][Full Text] [Related]
16. Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.
Yamaguchi Y; Moriki T; Igari A; Matsubara Y; Ohnishi T; Hosokawa K; Murata M
Thromb Res; 2013 Aug; 132(2):263-70. PubMed ID: 23777751
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
[TBL] [Abstract][Full Text] [Related]
18. Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy.
Sakariassen KS; Hanson SR; Cadroy Y
Thromb Res; 2001 Nov; 104(3):149-74. PubMed ID: 11672758
[TBL] [Abstract][Full Text] [Related]
19. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
[TBL] [Abstract][Full Text] [Related]
20. Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.
Nogami K; Ogiwara K; Yada K; Shida Y; Takeyama M; Yaoi H; Minami H; Furukawa S; Hosokawa K; Shima M
J Thromb Haemost; 2016 Apr; 14(4):667-74. PubMed ID: 27061057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
